> For the complete documentation index, see [llms.txt](https://nchvr.gitbook.io/nchvr-guidebook/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://nchvr.gitbook.io/nchvr-guidebook/study-specific-information/great-registry-follow-up.md).

# GREAT Registry (Follow-up)

https\://clinicaltrials.gov/ct2/show/NCT01658787

## What is being investigated?

GORE aortic products for abdominal aortic aneurysms.

## Who is the PI?

Dr. Mendes

## Who is the sponsor and/or CRO? How to contact them?

Sponsor: Gore

CRO: Fortrea

Contact: Vance, Amanda <amanda.vance@fortrea.com>

## Where to enter data and upload images?

**EDC:** iMedidata <https://login.imedidata.com/login?service=https%3A%2F%2Fwww.imedidata.com%2F>

**Images:** NA

**eTMF:** NA

## Upcoming Visits

This is a **registry** with **contiguous follow-up windows.** This means that there are no "out-of-window visits", any visit they come in for can be matched into one of the windows.&#x20;

*this is up to date as of 05 June 2023.*

## Tips/Quirks

* Back up coordinator: Soumya Sidana<br>
* This is a rather disorganised study. The sponsor/protocol has very vague definitions on what is required or expected. Monitoring has been loose (I don't think they ever monitored). <br>
* My suggestion is - do your best with it, try to keep an eye out for patients who come in for follow-ups, report AEs as you get notified about them, etc. Do NOT be a perfectionist with this study. <br>
* Rebecca is aware that this study is disorganised and I *think* she is going to try talk with the sponsors to see if we could end early. All this is to say - speak with her if you have any concerns about this study, she knows it is a challenging one to manage.&#x20;